SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997; 4: 13453.
  • 2
    Coetzer P, Lockyer I, Schorn D, Boshoff L. Quantitative disability evaluation of syndromes presenting with chronic fatigue. SAMJ 2000; 90: 103452.
  • 3
    Cohen H, Neumann L, Shore M, Amir M, Cassuto Y, Buskila D. Autonomic dysfunction in patients with fibromyalgia: application of power spectral analysis of heart rate variability. Semin Arthritis Rheum 2000; 29: 21727.
  • 4
    Rowe PC, Bou Holaigah I, Kan JS, Calkins H. Is neurally mediated hypotension an unrecognised cause of chronic fatigue? Lancet 1995; 345: 6234.
  • 5
    Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR. Responses of the sympathetic nervous system and the hypothalamic–pituitary–adrenal axis to interleukin-6: a pilot study in fibromyalgia. Arthritis Rheum 2000; 43: 87280.
  • 6
    Scott LV, The J, Reznek R, Martin A, Sohaib A, Dinan TG. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Psychoneuroendocrinology 1999; 24: 75968.
  • 7
    Demitrack MA, Dale JK, Straus SE et al. Evidence for impaired activation of the hypothalamic–pituitary–adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 122434.
  • 8
    Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 2001; 13: 11727.
  • 9
    Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp 130. Blood 1990; 86: 124354.
  • 10
    Lloyd A, Gandevia S, Brockman A, Hales J, Wakefield D. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 1994; 1: 1426.
  • 11
    Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 2001; 40: 7439.
  • 12
    Cannon JG, Angel JB, Ball RW, Abad LW, Fagioli L, Komaroff AL. Acute phase responses and cytokine secretion in chronic fatigue syndrome. J Clin Immunol 1999; 19: 41421.
  • 13
    Chao CC, Janoff EN, Hu SX et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 3: 2928.
  • 14
    Gupta S, Aggarwal S, See D, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiat Res 1997; 31: 14956.
  • 15
    Swanink CM, Vercoulen JH, Galama JM et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J Infect Dis 1996; 173: 4603.
  • 16
    Wolfe f Smythe HA, Yunus MB et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 16072.
  • 17
    Sharpe MC, Archard LC, Banatvala JE et al. A report − chronic fatigue syndrome: guidelines for research. J Roy Soc Med 1991; 84: 11821.
  • 18
    White KP, Speechley M, Harth M, Ostbye T. Co-existance of chronic fatigue syndrome with fibromyalgia syndrome in the general population. A controlled study. Scand J Rheumatol 2000; 29: 4451.
  • 19
    Amel Kashipaz MR, Huggins ML, Lanyon P, Robins A, Todd I, Powell RJ. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8 and CD8+ T cells in systemic lupus erythematosus. J Autoimmunity 2001; 17: 15563.
  • 20
    Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. J Psychosom Res 1993; 37: 14753.
  • 21
    Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17: 197210.
  • 22
    Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: a simple of impairment in functioning. Br J Psychiatry 2002; 180: 4614.
  • 23
    Bonaccorso S, Lin AH, Verkerk R et al. Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. J Affect Disord 1998; 48: 7582.
  • 24
    Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 14313.
  • 25
    Gallay P, Jongeneel VV, Barras C et al. Short time exposure to lipopolysaccharide is sufficient to activate human monocytes. J Immunol 1993; 150: 508693.
  • 26
    Yabuchi K, Maruta E, Yamamoto J et al. Intracerebroventricular injection of isoproterenol produces its analgesic effect through interleukin-1 beta production. Eur J Pharmacol 1997; 334: 13340.
  • 27
    Vollmer-Conna U, Lloyd A, Hickie I, Wakefield D. Chronic fatigue syndrome: an immunological perspective. Aust NZ J Psychiatry 1998; 32: 5237.